에 대한 최신 뉴스 Quantum-Si (NASDAQ:QSI) 주식

QUANTUM-SI INC

Quantum-Si

Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.

Quantum-Si (QSI)

Biotech

Technicals

Tech

Trading Ideas

General

퀀텀-Si(NASDAQ:QSI)는 지난 6개월 동안 327%라는 놀라운 급등세로 바이오텍의 주목을 받고 있다. 단백질체학의 선구자인 퀀텀-Si의 주가는 월요일 종가는 $4.10로, 강력한 상승 추세를 보이며 투자자들의 관심을 끌고 있었다. 

6개월간 327% 급등한 퀀텀-SI: 엔비디아가 더 많은 이익을 위한 촉매제일까?

Cathie Wood Buys Amazon, AMD Stock — Trims Palantir, Block Holdings Amid AI And Bitcoin Euphoria

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

News

Markets

ETFs

ARK 21Shares Bitcoin ETF ARK 21Shares Bitcoin ETF

ARKB

ARKG

ARKW

PLTR

RXRX

금요일에 캐시 우드가 이끄는 아크 인베스트(Ark Invest)가 팔란티어 테크놀로지스(NASDAQ:PLTR), Ark 21Shares Bitcoin ETF(BATS:ARKB) 그리고 퀀텀-Si(NASDAQ:QSI)와 관련된 중요한 거래를 진행했다.

캐시 우드의 아크 인베스트, 핫한 AI 주식 팔란티어로 이익 실현하고, 비트코인 ETF 주식 매도

Quantum-Si Incorporated - Class A Common Stock

Quantum-Si Inc

WisdomTree U.S. Short Term Corporate Bond Fund

Pacer Metaurus Nasdaq 100 Dividend Multiplier 600 ETF

EKSO

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

LYEL

APDN

Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) has outperformed the market over the past 15 years by 3.91% on an annualized basis producing an average annual return of 16.06%. Currently, Cigna Group has a market capitalization of $85.84 billion. 
Buying $100 In CI: If an investor had bought $100 of CI stock 15 years ago, it would be worth $929.38 today based on a price of $316.64 for CI at the time of writing.
<h3>Cigna Group's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748648720_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Cigna Group 15 Years Ago Would Be Worth Today

If you've ever assumed retirement meant having a seven-figure nest egg, you're in good company — and maybe a little stressed.
For years, Americans have treated the $1 million mark as the gold standard for retiring comfortably. Anything less? Cue the panic attacks.
But according to Northwestern Mutual's just-released <a href="https://news.northwesternmutual.com/planning-and-progress-study-2025">2025 Planning &amp; Progress Study</a>, the average American now believes they need $1.26 million tucked away to retire in peace. That's actually down from $1.46 million last year.
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Sure, the so-called magic number dropped by $200,000, but don't pop the champagne just yet. According to the same study, most Americans are <a href="https://www.benzinga.com/personal-finance/25/02/43856927/billionaire-blackrock-ceo-larry-fink-says-people-are-saving-too-much-and-not-investing-enough-to-retire-with-dignity">still wildly unprepared</a>. More than half – 51% – say it's somewhat or very likely they'll outlive their savings. Only 16% feel confident that outliving their savings is "very unlikely."&nbsp;&nbsp;
So if your retirement plan is "hope for the best," you're not alone.
The ‘magic number' to retire comfortably may be down this year, but it's still far beyond what many people actually have. And the gap isn't just wide — it's a canyon.&nbsp;
<a href="https://institutional.vanguard.com/insights-and-research/report/how-america-saves.html?cmpgn=IIG:TL:HAS:HAS24:SRCH:PS:XX:TL:GG:Unknown:Phrase:TLEAD:20230615:BD:NONE:NONE:KW:401kGeneral&amp;gclsrc=aw.ds&amp;gad_source=1&amp;gad_campaignid=17413933089&amp;gbraid=0AAAAADyd_RXD2epePnTlHlLRHWErHyW3U">Vanguard's 2024 report</a> puts the average 401(k) balance across all age groups at just $134,128. That's barely a tenth of what Americans say they'll need to retire comfortably.
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
And what's behind the drop? Inflation is still top of mind, but it's cooled off—dropping from around 6% in 2023 to <a href="https://www.bls.gov/opub/ted/2025/the-consumer-price-index-rose-3-0-percent-from-january-2024-to-january-2025.htm">about 3% in 2024</a>. That doesn't mean prices are falling; it just means they're not rising quite as fast. Groceries still feel like a splurge and rent still makes you cry, but apparently, that slight dip was enough for Americans to shave down their expectations.
Either way, the new target still feels like a stretch. <a href="https://www.benzinga.com/money/smartasset">One in four Americans has just a single year of income saved</a>. Among Gen X'ers, 52% have saved up to three times their annual income, but&nbsp; 54% don't think they'll be financially ready to retire when the time comes.<a href="https://www.asppa-net.org/news/2025/4/magic-number-for-retirement-drops-with-inflation/">&nbsp;</a>
Which raises a fair question—not from a study or expert, just plain observation: Are Americans adjusting the number because they think they can genuinely live on less, or have they just accepted that $1.26 million sounds more reachable than $1.46 million? Maybe this is optimism. Maybe it's financial fatigue.&nbsp;
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
If you're wondering how anyone hits that $1.26 million target: you either start young or start wealthy. To get there by age 65, a 20-year-old would need to sock away $330 a month at a 7% return. <a href="https://www.benzinga.com/personal-finance/24/08/40295808/youre-40-50-or-60-do-you-know-how-much-you-should-have-saved-for-retirement-by-now">Wait until you're 50? </a>That jumps to a casual $3,958 per month.<a href="https://www.asppa-net.org/news/2025/4/magic-number-for-retirement-drops-with-inflation/">&nbsp;</a>
Yes, the goal dipped—but the struggle to reach it hasn't. Americans may be adjusting expectations, but most still have a long way to go before <a href="https://www.benzinga.com/money/are-you-rich">retirement feels anything close to "comfortable."</a>
Read Next:
<ul class="wp-block-list">
<li>Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Image: Shutterstock

Personal Finance

Can You Guess What Americans Think They Need To Retire Comfortably? Hint: The 'Magic Number' Just Dropped From Last Year

<ul class="wp-block-list">
<li>The U.S. Department of Health and Human Services says that around 57% of Americans will need long-term care at some point</li>
<li>Most households have grossly underestimated the potential cost of that long-term care, and aren't aware that they will have to pay out of pocket for much of it</li>
<li>The total cost of long-term care can be significant, extending beyond $100,000</li>
</ul>
Long-term care costs can be significant, extending well beyond $100,000, but experts tell <a href="https://www.cnbc.com/2025/05/17/why-long-term-care-costs-can-be-a-huge-problem.html">CNBC</a> that most households aren't prepared to handle the expense.
"People don't plan for it in advance," certified financial planner Carolyn McClanahan told the network. "It's a huge problem."
A 2022 <a href="https://www.urban.org/research/publication/long-term-services-and-supports-older-americans">report</a> by the U.S. Department of Health and Human Services and the Urban Institute says that 57% of Americans turning 65 will develop a disability that is serious enough to require long-term care. The average cost of this long-term care is $122,400, the report said.
Don't Miss:
<ul class="wp-block-list">
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
On average, families will pay for 37% of the total cost of this long-term care out of pocket, with the rest covered by insurance and public programs.&nbsp;
"It's pretty clear [workers] don't have that amount of savings in retirement, that amount of savings in their checking or savings accounts, and the majority don't have long-term care insurance," Employee Benefit Research Institute strategist Bridget Bearden told CNBC. "So where is the money going to come from?"
Costs for long-term care vary widely, depending on where you live. However, <a href="https://www.carescout.com/cost-of-care">data</a> collected by Genworth and CareScout put the national average for a home health aide at $6,483 per month and $5,900 for a spot in an assisted living facility.&nbsp;
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
Still, many people grossly underestimate how much long-term care could potentially cost them. A recent Employee Benefit Research Institute <a href="https://www.ebri.org/health/content/employee-perspectives-on-long-term-care">report</a> found that "a significant proportion of future caregivers had not estimated LTC costs," and those who had expected them to remain under $50,000. Additionally, the report found that 43% of future caregivers expected Medicare to cover the costs of long-term care, and 29% expected Medicaid to foot the bill.
Experts told CNBC that estimates like these are not realistic. Health insurance generally doesn't cover long-term care services, and Medicare only covers select aspects, they say.
McClanahan told CNBC that Medicare typically covers skilled care for up to 100 days, which covers things like rehab or medicine administration, but will not cover the custodial care required for daily activities like bathing and dressing.&nbsp;
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
As for Medicaid, the largest payer of long-term care costs, not everyone will qualify. Most people who are eligible for these benefits come from low-income households. "You basically have to be destitute" for Medicaid to kick in, she said.
"The challenge with long-term care costs is they're unpredictable," McClanahan told CNBC. "You don't always know when you'll get sick and need care."&nbsp;
She advises Gen Xers and Millennials to begin planning for potential long-term care needs now. "When you think through it in advance, it keeps the decisions way more level-headed," she said.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

'It's A Huge Problem,' Experts Urge Gen Xers And Millennials To Plan For Long-Term Care

Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) has outperformed the market over the past 5 years by 9.52% on an annualized basis producing an average annual return of 23.37%. Currently, Intuitive Surgical has a market capitalization of $197.97 billion. 
Buying $100 In ISRG: If an investor had bought $100 of ISRG stock 5 years ago, it would be worth $288.38 today based on a price of $552.34 for ISRG at the time of writing.
<h3>Intuitive Surgical's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748647811_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ISRG

$100 Invested In Intuitive Surgical 5 Years Ago Would Be Worth This Much Today

NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) has outperformed the market over the past 15 years by 38.55% on an annualized basis producing an average annual return of 50.71%. Currently, NVIDIA has a market capitalization of $3.29 trillion. 
Buying $100 In NVDA: If an investor had bought $100 of NVDA stock 15 years ago, it would be worth $44,689.54 today based on a price of $134.77 for NVDA at the time of writing.
<h3>NVIDIA's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748646912_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NVDA

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

Comfort Systems USA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIX#NYSE">FIX</a>) has outperformed the market over the past 5 years by 51.3% on an annualized basis producing an average annual return of 65.16%. Currently, Comfort Systems USA has a market capitalization of $16.87 billion. 
Buying $100 In FIX: If an investor had bought $100 of FIX stock 5 years ago, it would be worth $1,256.85 today based on a price of $478.23 for FIX at the time of writing.
<h3>Comfort Systems USA's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748646010_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Comfort Systems USA 5 Years Ago Would Be Worth Today

IES Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IESC#NASDAQ">IESC</a>) has outperformed the market over the past 5 years by 47.83% on an annualized basis producing an average annual return of 61.68%. Currently, IES Hldgs has a market capitalization of $5.16 billion. 
Buying $100 In IESC: If an investor had bought $100 of IESC stock 5 years ago, it would be worth $1,103.53 today based on a price of $259.66 for IESC at the time of writing.
<h3>IES Hldgs's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748645112_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

IESC

$100 Invested In IES Hldgs 5 Years Ago Would Be Worth This Much Today

STLD

UPDATE: President Donald Trump Says He Would Be Increasing Tariffs On Steel To 50% From 25%; Tariffs To Go Into Effect Next Week

<a href="https://www.youtube.com/watch?v=xqnyP6mUI7w">https://www.youtube.com/watch?v=xqnyP6mUI7w</a>

President Trump Says U.S. Steel Will Be Controlled By USA; Says Steel Tariffs Go Into Effect Next Week

<a href="https://www.bloomberg.com/news/articles/2025-05-30/trump-to-raise-steel-tariffs-to-50-to-help-nippon-us-steel-deal?embedded-checkout=true" title="https://www.bloomberg.com/news/articles/2025-05-30/trump-to-raise-steel-tariffs-to-50-to-help-nippon-us-steel-deal?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-05-30/trump-to-raise-steel-tariffs-to-50-to-help-nippon-us-steel-deal?embedded-checkout=true</a>

'Trump to Raise Steel Tariffs to 50% to Help Nippon-US Steel Deal'- Bloomberg

In the current market session, Principal Financial Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFG#NASDAQ">PFG</a>) share price is at $77.89, after a 0.84% drop. Over the past month, the stock spiked by 1.38%, but over the past year, it actually fell by 3.53%. With good short-term performance like this, and questionable long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.

<img src="https://www.benzinga.com/files/images/story/2025/1748642422_0.png" alt="Past Year Chart" />

<h3>Principal Financial Group P/E Compared to Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Principal Financial Group has a better P/E ratio of 16.82 than the aggregate P/E ratio of 13.53 of the Insurance industry. Ideally, one might believe that Principal Financial Group Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1748642422_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Price Over Earnings Overview: Principal Financial Group

Constellation Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) has outperformed the market over the past 20 years by 1.42% on an annualized basis producing an average annual return of 9.7%. Currently, Constellation Brands has a market capitalization of $31.79 billion. 
Buying $100 In STZ: If an investor had bought $100 of STZ stock 20 years ago, it would be worth $634.94 today based on a price of $178.58 for STZ at the time of writing.
<h3>Constellation Brands's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748642418_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

<a href="https://www.bloomberg.com/news/articles/2025-05-30/trump-officials-set-for-talks-with-asia-leaders-on-alaska-energy?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-05-30/trump-officials-set-for-talks-with-asia-leaders-on-alaska-energy?embedded-checkout=true</a>

'Trump Officials Set for Talks With Asia Leaders on Alaska Energy'- Bloomberg

SBET

SharpLink Gaming Files For Mixed Shelf Offering; Size Not Disclosed

CELU

Celularity Receives Nasdaq Letter Regarding Form 10-Q

Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) has outperformed the market over the past 15 years by 5.91% on an annualized basis producing an average annual return of 18.07%. Currently, Salesforce has a market capitalization of $253.42 billion. 
Buying $1000 In CRM: If an investor had bought $1000 of CRM stock 15 years ago, it would be worth $11,841.59 today based on a price of $265.08 for CRM at the time of writing.
<h3>Salesforce's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748640629_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today

<ul>
<li>Updated interim results with an additional ~16 weeks of follow-up on nine patients in Cohort 1 (2.5 mCi) and Cohort 2 (5.0 mCi) and initial safety findings in an additional 33 patients treated in Cohort 2 from the ongoing Phase 1/2a study were presented</li>
<li>[212Pb]VMT-α-NET continued to have a favorable safety profile, with no dose-limiting toxicities and no discontinuations due to adverse events observed among a total of 42 patients who received at least one treatment</li>
<li>Four of seven patients in Cohort 2 experienced investigator-assessed objective responses as defined by RECIST v1.1. Three of those patients experienced confirmed response and remained in response. One new first response is subject to confirmation.</li>
<li>Seven of nine patients in Cohorts 1 and 2 remained free from disease progression after more than one year of follow-up</li>
<li>Perspective will hold a conference call on Monday, June 2, 2025 at 8:00 am ET &nbsp;</li>
</ul>

CATX

Perspective Therapeutics Reveals New Interim Data from its Ongoing Phase 1/2a Clinical Trial of [212Pb]VMT-α-NET At The 2025 ASCO Annual Meeting

Press Releases

Quantum-Si and Researchers to Showcase Next-Generation Protein Sequencing™ at US HUPO 2025

Quantum-Si's Customers and Researchers to Showcase Next-Generation Protein Sequencing™ at AGBT 2025

Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Power Metallic (TSXV: PNPN) Uses AI to Revolutionize Mining – Big Discoveries & More Tech Stocks Inside!

Quantum-Si to Participate in DNAnexus Webinar on Large Scale Proteomics in Multi-Omics Research

Quantum-Si Begins Shipping Platinum® Pro, Advancing Accessibility in Next-Gen Protein Sequencing™

Quantum-Si to Report First Quarter 2025 Financial Results on May 15, 2025

Dr. Gloria Sheynkman from the University of Virginia to Present Pioneering Research utilizing Quantum-Si's Next-Gen Protein Sequencing™ Platform in Upcoming Nature Webinar on May 15

Quantum-Si Reports First Quarter 2025 Financial Results

ACON

NAOV

PNPNF

PRSO

TSXV:PNPN

AbCellera Biologics

Atlantic International Corp. - Common Stock

Atlantic International

Azenta

BioLife Solutions

Codexis

Champions Oncology

Cytek Biosciences

CryoPort

Fortrea Holdings

Standard BioTools

Lifecore Biomedical

Mesa Laboratories

Maravai LifeSciences Holdings, Inc. - Class A common stock

Maravai LifeSciences

MaxCyte

Niagen Bioscience

Nautilus Biotechnology, Inc. - Common Stock

Nautilus Biotechnology

Inotiv

OmniAb

Pacific Biosciences of California, Inc. - Common Stock

Pacific Biosciences

Personalis

Quanterix

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems

Seer

Alpha Teknova

10x Genomics

Alliance Global Partners

Canaccord Genuity

퀀텀-Si(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSI#NASDAQ">QSI</a>)는 지난 6개월 동안 327%라는 놀라운 급등세로 <a href="https://www.benzinga.com/general/biotech">바이오텍의 주목을 받고</a> 있다.
단백질체학의 선구자인 퀀텀-Si의 주가는 월요일 종가는 $4.10로, 강력한 상승 추세를 보이며 투자자들의 관심을 끌고 있었다.
하지만 이러한 급등의 배경은 무엇이며, 이 모멘텀을 지속할 수 있을까? 화요일 이 주가는 약 15% 급락 마감했다.
<h2 class="wp-block-heading">퀀텀-Si 주식: 상승 요인 분석</h2>
기술적 관점에서 퀀텀-Si 주식은 최근 <a href="https://kr.benzinga.com/?s=%EA%B3%A8%EB%93%A0+%ED%81%AC%EB%A1%9C%EC%8A%A4" target="_blank" rel="noopener">골든 크로스</a>(Golden Cross)를 기록하며 상승 신호를 보였다.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent010725&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" class="wp-image-721814" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/07084031/Screenshot-2025-01-07-at-6.54.50-PM.png" sizes="(max-width: 628px) 100vw, 628px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/07084031/Screenshot-2025-01-07-at-6.54.50-PM.png 628w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/07084031/Screenshot-2025-01-07-at-6.54.50-PM-300x231.png 300w" alt="" width="628" height="483" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent010725&amp;t=be2bearmibe3na1">차트는 Benzinga Pro를 사용하여 생성되었습니다.</a>
QSI 주식은 8일($3.54), 20일($2.37), 50일($1.54)의 주요 단순 이동 평균(SMA) 위에서 안정적으로 거래되고 있었다. 200일 SMA인 $1.32도 강세를 나타낸다.
이동 평균 수렴/발산(MACD) 지표가 0.72로 상승 추세를 지원하고 있지만, 상대 강도 지수(RSI)가 67.01로 주식이 과매수 영역에 가까워지고 있음을 나타내어 단기 매도 압박이 있을 수 있다.
추가로 읽어보세요: <a href="https://www.benzinga.com/insights/options/25/01/42826559/spotlight-on-quantum-si-analyzing-the-surge-in-options-activity">퀀텀-Si의 주목: 옵션 거래 급증 분석</a>
<h2 class="wp-block-heading">QSI 주가 급등의 원인은?</h2>
퀀텀-Si의 급속한 상승은 전략적 재정비와 기술 혁신의 조합에서 비롯되었다. 이 회사의 구조조정 노력, 인력 감축 및 주요 제품인 프로테우스(Proteus) 단백질체학 플랫폼에 대한 집중 강화가 운영을 간소화하고 투자자 신뢰를 높였다.
엔비디아와의 파트너십은 인공지능(AI) 기반 기능을 강화하여 프로테우스를 개인 맞춤형 의학의 게임 체인저로 자리매김하게 했다. 이 협력은 퀀텀-Si가 방대한 양의 단백질체학 데이터를 실시간으로 처리할 수 있게 하여 진단 및 신약 개발의 속도와 정확성을 높인다.
<h2 class="wp-block-heading">앞으로의 전망: 2025년 및 그 이후</h2>
퀀텀-Si가 52주 최고가인 $5.77를 지나 치고 나가면서, 모든 시선은 회사의 미래 잠재력에 집중되고 있다.이  회사는 농업, 환경 모니터링, 고급 신약 개발 등 새로운 기술 응용 분야를 타겟으로 하고 있다.
프로테우스를 효과적으로 상용화하고 시장 점유율을 확장할 수 있다면, 2025년은 퀀텀-Si를 바이오텍 강자로 확립할 수 있는 기회가 될 것이다.
강력한 기술적 기반, 획기적인 기술, 전략적 파트너십이 결합된 퀀텀-Si는 떠오르는 바이오텍 스타가 되고 있다.
그러나 RSI가 과매수 영역에 가까워지고 있다는 것은 주식이 급등세를 이어가는 동안 신중한 낙관론이 필요하다는 것을 시사한다.
이 회사가 2025년으로 나아가면서, 퀀텀-Si는 단백질체학의 미래에 베팅하는 투자자들이 주목해야 할 기업으로 남아 있다.
주가 움직임: 퀀텀-SI의 주식은 화요일 14.76% 급락한 $3.05에 마감되었다. 이후 시간외 거래에서 3.00% 추가 하락했다.
다음 읽기: 
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/01/42827918/viking-therapeutics-structure-therapeutics-positioned-as-key-pharma-partners-for-weight-loss-products-analyst">바이킹 테라퓨틱스, 스트럭처 테라퓨틱스: 체중 감량 제품의 주요 제약 파트너로 자리매김</a></li>
</ul>
이미지 출처: Quantum-Si
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

금요일에 캐시 우드가 이끄는 아크 인베스트(Ark Invest)가 팔란티어 테크놀로지스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), Ark 21Shares Bitcoin ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKB#BATS">ARKB</a>) 그리고 퀀텀-Si(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSI#NASDAQ">QSI</a>)와 관련된 중요한 거래를 진행했다.
PLTR 거래
아크 인베스트는 팔란티어 주식 20,332주를 매도했다. 이 움직임은 최근 <a href="https://www.benzinga.com/24/12/42696614/cathie-wood-takes-profit-on-hot-ai-stock-palantir-again-continues-to-sell-block-shares-amid-bitcoin-buzz">핫한 인공지능(AI) 주식</a>에 대한 포지션을 줄이는 추세와 일치한다. 매도는 ARK 혁신 ETF를 통해 실행되었다. 매매가는 마지막 종가인 $79.89를 기준으로 계산했을 때, 거래 가치는 약 160만 달러이다.
ARKB 거래
비트코인이 <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42334991/as-bitcoin-hits-100k-for-the-first-time-ark-invests-cathie-wood-calls-it-a-much-bigger-idea-than-gold-and-that-it-is-still-is-in-early-innings">처음으로 10만 달러를 넘어섰을 때</a>, 아크 인베스트의 ETF인 ARK 21Shares Bitcoin ETF가 주목받게 되었다. 비트코인 옹호자로 잘 알려진 캐시 우드는 암호화폐의 역사적인 랠리를 축하했다.
이 투자 회사는 일부 이익을 실현하고 비트코인 ETF 주식 18,476주를 ARK 차세대 인터넷 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>)를 통해 매도했다.
기타 주요 거래:
퀀텀-Si: 아크 인베스트는 ARK 유전체 혁명 ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>)를 통해 주식 452,570주를 매도했다.
템포 AI(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>): ARKG를 통해 주식 53,376주를 매입했다.
리커젼 파마슈티컬스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>): ARKG를 통해 주식 44,887주를 매입했다.
다음 읽기:
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EB%A1%9C%EB%B9%88%ED%9B%97-250%EB%A7%8C-%EB%8B%AC%EB%9F%AC%EC%9D%98-%EB%B9%84%ED%8A%B8%EC%BD%94%EC%9D%B8-%EB%8F%84%EC%A7%80%EC%BD%94%EC%9D%B8-%EC%84%A0%EB%AC%BC%EB%A1%9C-%EC%83%88%ED%95%B4/" target="_blank" rel="noopener">로빈후드가 새해를 맞이하여 250만 달러 상당의 비트코인, 도지코인 경품 이벤트를 진행합니다.</a></li>
</ul>
면책 조항: 이 내용은 부분적으로 AI 도구의 도움을 받아 작성되었으며, Benzinga 편집자에 의해 검토 및 게시되었습니다.
사진 출처: Shutterstock
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Quantum-Si

뉴스

에 대한 최신 뉴스 Quantum-Si (NASDAQ:QSI) 주식

화요일, 1월 07, 2025

토요일, 1월 04, 2025

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌